WASHINGTON, Jan. 27, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2021. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended December 31, 2021, net earnings were $1.8 billion, or $2.39 per diluted common share which represents a... Read more
Fourth quarter 2021 revenue and earnings per share to exceed prior guidance Non-COVID organic growth in fourth quarter 2021 of approximately 10% Fourth quarter 2021 COVID product and services related revenue of approximately $320 million WALTHAM, Mass.–(BUSINESS WIRE)–Jan. 11, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today... Read more
Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteins WALTHAM, Mass., Jan. 5, 2022 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc., a leading developer and manufacturer of recombinant proteins, today announced that Thermo Fisher completed its acquisition of PeproTech on December 30, 2021 for a total cash... Read more
Thermo Fisher Scientific Updates TaqMan SARS-CoV-2 Mutation Panel to Enable Direct Identification of Omicron Variant CARLSBAD, Calif., Dec. 21, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced an update to its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to enable direct detection of the Omicron SARS-CoV-2 variant. The panel is designed... Read more
Polivy plus R-CHP is the first treatment regimen to significantly improve outcomes in previously untreated diffuse large B-cell lymphoma in more than 20 years, potentially transforming treatment for people with this disease Four out of ten people receiving the current standard of care for this type of disease will see their cancer return after initial... Read more
People with moderate or mild haemophilia A have significant unmet clinical needs, as this population may not use preventative treatments due to missed or delayed diagnoses of bleeding episodes and a lack of treatment guidelines1,2 New data indicate that Hemlibra has a favourable safety profile in people with moderate or mild haemophilia A without factor... Read more
Results to be presented for the first time show mosunetuzumab induces high and durable complete response rates in people with follicular lymphoma who have received two or more prior therapies1 New efficacy data from Roche’s portfolio of cancer immunotherapies demonstrate potential of bispecific antibodies to expand upon current treatment options across several blood cancers Basel,... Read more
Thermo Fisher Scientific Completes Acquisition of PPD, Inc. WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for... Read more
New NGS workflow accelerates the detection of SARS-CoV-2 variants including Omicron WALTHAM, Mass.–(BUSINESS WIRE)–Dec. 8, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the research use only (RUO) launch of the NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit v2 to accelerate the detection of SARS-CoV-2 variants. This complete next... Read more
3D printing offers great flexibility in the creation of precisely engineered objects with highly complex geometries. This is rapidly opening up possibilities in many fields, including aerospace, robotics, construction and medicine. External content Nature Communications: 3D printing of inherently nanoporous polymers via polymerization-induced phase separation 3D printing offers enormous flexibility in fabrication of polymer objects... Read more